Physician profile
Itzhak C Haimovic
NPI 1629075767
$7,358.76
in general payments reported to CMS, 2019-2025
49 companies · $1,776 in 2025
The $1,776 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $762 · 2021: $1,412 · 2022: $1,037 · 2023: $528 · 2024: $1,202 · 2025: $1,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,505.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,807.81 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $899.17 | 2019-2025 | |
| Pfizer INC. | $442.07 | 2021-2025 | |
| Allergan, INC. | $380.01 | 2019-2022 | |
| Horizon Therapeutics Plc | $354.56 | 2021-2023 | Uplizna |
| Biohaven Pharmaceuticals, INC. | $323.22 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $295.86 | 2019-2023 | Soliris |
| Sk Life Science, INC. | $249.04 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $236.98 | 2020-2022 | |
| Eisai INC. | $226.13 | 2020-2025 | |
| Medtronic, INC. | $195.82 | 2021-2025 | Percept PC Brainsense |
| Avanir Pharmaceuticals, INC. | $178.80 | 2021-2022 | |
| Neurelis, INC. | $172.40 | 2025 | Valtoco |
| Lundbeck LLC | $166.08 | 2022-2025 | Vyepti, Rexulti |
| Catalyst Pharmaceuticals, INC. | $109.48 | 2020-2023 | Fycompa |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itzhak Haimovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.